Synmosa Biopharma Corporation (TPEX: 4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
34.80
-0.10 (-0.29%)
Nov 22, 2024, 1:30 PM CST

Synmosa Biopharma Company Description

Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan.

It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology.

The company provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms.

It also offers contract manufacturing services. In addition, it exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua.

Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.

Synmosa Biopharma Corporation
Country Taiwan
Founded 1980
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
CEO Chih-Hui Lin

Contact Details

Address:
No. 396, Neihu Road
Taipei, 114
Taiwan
Phone 886 2 8797 7100
Website synmosa.com.tw

Stock Details

Ticker Symbol 4114
Exchange Taipei Exchange
Fiscal Year January - December
Reporting Currency TWD
ISIN Number TW0004114004
SIC Code 2834

Key Executives

Name Position
Chih-Hui Lin Chairman, GM, Managerial Officer and President
Hong-Qin Bai Senior Vice President and Finance Officer
Jia-Xin Zhang Senior Vice President
Sheng-Ren Yang Senior Vice President
Liyu Huang Chief Financial Officer
Jinghua Cao Accounting Supervisor
Zen Young Vice President of Sales - HP, Marketing and Medical